Renaissance Technologies’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $581K | Sell |
49,900
-55,985
| -53% | -$652K | ﹤0.01% | 2760 |
|
2025
Q1 | $787K | Sell |
105,885
-123,900
| -54% | -$921K | ﹤0.01% | 2547 |
|
2024
Q4 | $1.38M | Buy |
229,785
+60,385
| +36% | +$362K | ﹤0.01% | 2301 |
|
2024
Q3 | $867K | Buy |
169,400
+17,600
| +12% | +$90.1K | ﹤0.01% | 2533 |
|
2024
Q2 | $550K | Buy |
151,800
+99,217
| +189% | +$359K | ﹤0.01% | 2656 |
|
2024
Q1 | $169K | Buy |
+52,583
| New | +$169K | ﹤0.01% | 3268 |
|
2023
Q4 | – | Sell |
-51,200
| Closed | -$279K | – | 3694 |
|
2023
Q3 | $279K | Sell |
51,200
-287,300
| -85% | -$1.57M | ﹤0.01% | 2960 |
|
2023
Q2 | $2.27M | Sell |
338,500
-55,500
| -14% | -$372K | ﹤0.01% | 1919 |
|
2023
Q1 | $3.48M | Sell |
394,000
-21,800
| -5% | -$192K | ﹤0.01% | 1691 |
|
2022
Q4 | $3.18M | Sell |
415,800
-42,000
| -9% | -$321K | ﹤0.01% | 1779 |
|
2022
Q3 | $3.26M | Sell |
457,800
-28,700
| -6% | -$204K | ﹤0.01% | 1709 |
|
2022
Q2 | $3.94M | Buy |
486,500
+30,900
| +7% | +$250K | ﹤0.01% | 1733 |
|
2022
Q1 | $6.32M | Buy |
+455,600
| New | +$6.32M | 0.01% | 1423 |
|
2021
Q2 | – | Sell |
-160,200
| Closed | -$6.45M | – | 3417 |
|
2021
Q1 | $6.45M | Buy |
+160,200
| New | +$6.45M | 0.01% | 1495 |
|